Showing results (1531-1540 of 6,884) with videos related to
Sort By:
Pageof 689
Leukemia Research|August 11, 2012
Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillanceVibe Skov, Thomas Stauffer Larsen, Mads Thomassen, et al.Leukemia Research|September 4, 2012
ER stress in diffuse large B cell lymphoma: GRP94 is a possible biomarker in germinal center versus activated B-cell typeJerina Boelens, Jean-Philippe Jais, Barbara Vanhoecke, et al.Leukemia Research|September 4, 2012
The classification of MDS: from FAB to WHO and beyondJames VardimanLeukemia Research|October 27, 2012
Physical activity of pediatric patients with acute leukemia undergoing induction or consolidation chemotherapySue Yee Tan, Bee Koon Poh, Hui Xian Chong, et al.Leukemia Research|October 30, 2012
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosisAdi Diab, Lynette Zickl, Omar Abdel-Wahab, et al.Leukemia Research|October 4, 2012
Therapy-related acute myeloid leukemia with favorable cytogenetics: still favorable?Ibrahim Aldoss, Vinod PullarkatLeukemia Research|July 27, 2020
Antihistamines are synergistic with Bruton's tyrosine kinase inhibiter ibrutinib mediated by lysosome disruption in chronic lymphocytic leukemia (CLL) cellsAaron Chanas-Larue, Gloria E Villalpando-Rodriguez, Elizabeth S Henson, et al.Leukemia Research|July 30, 2020
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal typeLiqiang Wei, Liang Wang, Jia Cong, et al.Leukemia Research|August 12, 2020
MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab eraNoriko Nishimura, Kengo Takeuchi, Reimi Asaka, et al.Pageof 689